BankPlus Trust Department Has $888,000 Holdings in Encompass Health Corporation $EHC

BankPlus Trust Department grew its position in Encompass Health Corporation (NYSE:EHC) by 728.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,994 shares of the company’s stock after purchasing an additional 6,150 shares during the quarter. BankPlus Trust Department’s holdings in Encompass Health were worth $888,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. EP Wealth Advisors LLC boosted its stake in Encompass Health by 2.4% in the 2nd quarter. EP Wealth Advisors LLC now owns 3,694 shares of the company’s stock valued at $453,000 after purchasing an additional 88 shares during the period. Natural Investments LLC boosted its position in shares of Encompass Health by 1.2% in the third quarter. Natural Investments LLC now owns 7,808 shares of the company’s stock valued at $991,000 after acquiring an additional 89 shares during the period. Pinnacle Wealth Planning Services Inc. grew its stake in shares of Encompass Health by 4.0% in the first quarter. Pinnacle Wealth Planning Services Inc. now owns 2,597 shares of the company’s stock valued at $263,000 after acquiring an additional 99 shares in the last quarter. Securian Asset Management Inc. increased its position in Encompass Health by 1.3% during the second quarter. Securian Asset Management Inc. now owns 7,716 shares of the company’s stock worth $946,000 after acquiring an additional 100 shares during the period. Finally, State of Michigan Retirement System raised its stake in Encompass Health by 0.4% in the 2nd quarter. State of Michigan Retirement System now owns 24,245 shares of the company’s stock worth $2,973,000 after purchasing an additional 100 shares in the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

EHC has been the topic of a number of analyst reports. Weiss Ratings restated a “buy (b+)” rating on shares of Encompass Health in a research report on Wednesday, October 8th. Wall Street Zen raised Encompass Health from a “hold” rating to a “buy” rating in a research report on Sunday, November 23rd. KeyCorp raised their price objective on Encompass Health from $135.00 to $140.00 and gave the stock an “overweight” rating in a research note on Tuesday, September 16th. Zacks Research downgraded Encompass Health from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 19th. Finally, Bank of America increased their target price on Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a report on Wednesday, September 10th. Two research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $142.86.

Encompass Health Trading Up 0.5%

Shares of EHC stock opened at $107.61 on Friday. Encompass Health Corporation has a fifty-two week low of $87.85 and a fifty-two week high of $127.99. The stock’s fifty day moving average price is $114.32 and its two-hundred day moving average price is $117.94. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.14 and a current ratio of 1.14. The company has a market cap of $10.83 billion, a PE ratio of 20.34, a P/E/G ratio of 1.90 and a beta of 0.73.

Encompass Health (NYSE:EHC) last announced its quarterly earnings data on Wednesday, March 16th. The company reported $0.93 earnings per share for the quarter. The business had revenue of $136.30 million during the quarter. Encompass Health had a return on equity of 17.84% and a net margin of 9.33%.Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. Equities analysts predict that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be paid a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Friday, January 2nd. Encompass Health’s dividend payout ratio (DPR) is presently 14.37%.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.